{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:08:41Z","timestamp":1775056121347,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.reumae.2026.502078","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:22:25Z","timestamp":1773836545000},"page":"502078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of comorbidities and medication use in progressive systemic sclerosis in northeast Mexico"],"prefix":"10.1016","volume":"22","author":[{"given":"Jorge Armando","family":"Hermosillo-Villafranca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Joselin","family":"Rodarte-Gallegos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 131","key":"10.1016\/j.reumae.2026.502078_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.55563\/clinexprheumatol\/izadb8","article-title":"One year in review 2021: systemic sclerosis","volume":"39","author":"Di Battista","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reumae.2026.502078_bib0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/kjm2.12505","article-title":"Pathophysiology of systemic sclerosis (scleroderma)","volume":"38","author":"Rosendahl","year":"2022","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.reumae.2026.502078_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102211","article-title":"Current advances in the treatment of systemic sclerosis","volume":"64","author":"Bukiri","year":"2022","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.reumae.2026.502078_bib0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.reuma.2014.01.011","article-title":"Esclerodermia en el Caribe: caracter\u00edsticas en una serie de casos dominicana","volume":"10","author":"Paola Gottschalk","year":"2014","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reumae.2026.502078_bib0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejim.2024.07.040","article-title":"Towards a comprehensive approach to the management and prognosis of systemic sclerosis\u2019s patients: the role of comorbidities in the SPRING-SIR registry","volume":"130","author":"Orlandi","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.reumae.2026.502078_bib0030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13075-018-1771-0","article-title":"Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: A comparative, multicenter, matched-cohort study","volume":"20","author":"Panopoulos","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.reumae.2026.502078_bib0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/23971983221145788","article-title":"Comprehensive description of the prevalence, serological and clinical characteristics, and visceral involvement of systemic sclerosis (scleroderma) in a large cohort from the United Arab Emirates Systemic Sclerosis Registry","volume":"8","author":"Namas","year":"2023","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.reumae.2026.502078_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004637","article-title":"Comorbidity burden on mortality in patients with systemic sclerosis","volume":"10","author":"Fauthoux","year":"2024","journal-title":"RMD Open"},{"issue":"Supl 3","key":"10.1016\/j.reumae.2026.502078_bib0045","first-page":"S363","article-title":"Caracter\u00edsticas de los pacientes con esclerosis sist\u00e9mica que desarrollan enfermedad pulmonar inters-ticial","volume":"61","author":"Fajardo-Hermosillo","year":"2023","journal-title":"Rev Med Inst Mex Seguro Soc"},{"key":"10.1016\/j.reumae.2026.502078_bib0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/23971983221086214","article-title":"Systemic sclerosis manifestations and clinical outcomes in Hispanics\/Latinos of the American Southwest","volume":"7","author":"Nunez","year":"2022","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.reumae.2026.502078_bib0055","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3109\/08916934.2011.592886","article-title":"Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients","volume":"44","author":"Rodriguez-Reyna","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.reumae.2026.502078_bib0060","first-page":"476","article-title":"Prevalencia de s\u00edndrome metab\u00f3lico y resistencia a la insulina en esclerosis sist\u00e9mica","volume":"53","author":"Peralta-Amaro","year":"2015","journal-title":"Rev Med Inst Mex Seguro Soc"},{"key":"10.1016\/j.reumae.2026.502078_bib0065","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3899\/jrheum.081134","article-title":"Validity of self-reported comorbidities in systemic sclerosis","volume":"36","author":"Hudson","year":"2009","journal-title":"J Rheumatol"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217357432600033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217357432600033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T13:25:23Z","timestamp":1775049923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S217357432600033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S217357432600033X"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2026.502078","relation":{},"ISSN":["2173-5743"],"issn-type":[{"value":"2173-5743","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of comorbidities and medication use in progressive systemic sclerosis in northeast Mexico","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2026.502078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2026.502078","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Reumatolog\u00eda (SER), Colegio Mexicano de Reumatolog\u00eda (CMR) and Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502078"}}